These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7097421)

  • 41. Pseudohypoaldosteronism: family studies to identify asymptomatic carriers by stimulation of the renin-aldosterone system.
    Kuhnle U; Hinkel GK; Hubl W; Reichelt T
    Horm Res; 1996; 46(3):124-9. PubMed ID: 8894667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Multiple type I pseudohypoaldosteronism: neonatal management and outcome].
    Cristina De Frutos Martínez M; Elorza Martínez M; Salas Hernández S; García Sánchez P; Jaso Cortés E; Pérez-Rodríguez J; Quero Jiménez J
    An Esp Pediatr; 2000 Jan; 52(1):47-51. PubMed ID: 11003859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperaldosteronism in pregnancy.
    Escher G
    Ther Adv Cardiovasc Dis; 2009 Apr; 3(2):123-32. PubMed ID: 19171690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Newborn with pseudohypoaldosteronism and miliaria rubra.
    Akcakus M; Koklu E; Poyrazoglu H; Kurtoglu S
    Int J Dermatol; 2006 Dec; 45(12):1432-4. PubMed ID: 17184247
    [No Abstract]   [Full Text] [Related]  

  • 46. Pseudohypoaldosteronism.
    Riepe FG
    Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
    Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyporeninemic hypoaldosteronism, sodium wasting and mineralocorticoid-resistant hyperkalemia in two patients with obstructive uropathy.
    Pelleya R; Oster JR; Perez GO
    Am J Nephrol; 1983; 3(4):223-7. PubMed ID: 6351617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudohypoaldosteronism: mineralocorticoid unresponsiveness syndrome.
    Jaruratanasirikul S; Janjindamai W
    J Med Assoc Thai; 2000 Aug; 83(8):948-52. PubMed ID: 10998851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. II. Measurement of sweat sodium and potassium excretion as a screening test of mineralocorticoid excess in hypertensive patients.
    Grandchamp A; Veyrat R; Scholer D; Muller AF
    Helv Med Acta; 1969 May; 35(1):55-71. PubMed ID: 5772695
    [No Abstract]   [Full Text] [Related]  

  • 52. [Salt-losing syndrome in newborn infants with hyperaldosteronism. Presenting a sensitivity to mineralocorticoids. Pseudohypoaldosteronism].
    Tieder M; Vure E; Gulboa Y; Rosenberg T; Modai D
    Arch Fr Pediatr; 1976 May; 33(5):485-96. PubMed ID: 973780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
    Zech P; Pozet N; Sassard J; Leitienne P; Blanc N; Colon S; Berthoux F; Touraine JL; Traeger J
    J Urol Nephrol (Paris); 1974 Sep; 80(9):760-5. PubMed ID: 4463254
    [No Abstract]   [Full Text] [Related]  

  • 54. Chronic hyperaldosteronism in cryptochrome-null mice induces high-salt- and blood pressure-independent kidney damage in mice.
    Nugrahaningsih DA; Emoto N; Vignon-Zellweger N; Purnomo E; Yagi K; Nakayama K; Doi M; Okamura H; Hirata K
    Hypertens Res; 2014 Mar; 37(3):202-9. PubMed ID: 24108235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renin-aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes.
    Hanukoglu A; Edelheit O; Shriki Y; Gizewska M; Dascal N; Hanukoglu I
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):268-74. PubMed ID: 18634878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are there unknown mineralocorticoids in low-renin essential hypertension?
    Hollifield JW; Slaton PE; Wilson HM; Sennett JA; Yarbro L; Island DP; Liddle GW
    Mayo Clin Proc; 1977 May; 52(5):329-33. PubMed ID: 323587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Aldosterone in Obesity-Related Hypertension.
    Kawarazaki W; Fujita T
    Am J Hypertens; 2016 Apr; 29(4):415-23. PubMed ID: 26927805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic responses to the administration of angiotensin II, K and ACTH in two salt-wasting syndromes.
    Rösler A; Theodor R; Boichis H; Gerty R; Ulick S; Alagem M; Tabachinik E; Cohen B; Rabinowitz D
    J Clin Endocrinol Metab; 1977 Feb; 44(2):292-301. PubMed ID: 190253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Failure to thrive, hyponatremia, and hyperkalemia in a neonate.
    Sopfe J; Simmons JH
    Pediatr Ann; 2013 May; 42(5):74-9. PubMed ID: 23641881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.